Joseph L. Kim

Person

  • Wayland, MA, US

Patents Grantslast 30 patents

  • Information Patent Grant

    Wild type kit inhibitors

    • Patent number 12,269,824
    • Issue date Apr 8, 2025
    • Blueprint Medicines Corporation
    • Jason D. Brubaker
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    EGFR inhibitors

    • Patent number 12,172,983
    • Issue date Dec 24, 2024
    • Blueprint Medicines Corporation
    • John Emmerson Campbell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    MAP4K1 inhibitors

    • Patent number 12,042,495
    • Issue date Jul 23, 2024
    • Blueprint Medicines Corporation
    • Jason D. Brubaker
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    CDK2 inhibitors

    • Patent number 11,970,498
    • Issue date Apr 30, 2024
    • Blueprint Medicines Corporation
    • Douglas Wilson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CDK2 inhibitors

    • Patent number 11,932,648
    • Issue date Mar 19, 2024
    • Blueprint Medicines Corporation
    • Douglas Wilson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compositions useful for treating disorders related to KIT

    • Patent number 11,827,642
    • Issue date Nov 28, 2023
    • Blueprint Medicines Corporation
    • Brian L. Hodous
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    EGFR inhibitors

    • Patent number 11,718,602
    • Issue date Aug 8, 2023
    • Blueprint Medicines Corporation
    • Natasja Brooijmans
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Inhibitors of activin receptor-like kinase

    • Patent number 11,634,422
    • Issue date Apr 25, 2023
    • Blueprint Medicines Corporation
    • Natasja Brooijmans
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    MAP4K1 inhibitors

    • Patent number 11,534,441
    • Issue date Dec 27, 2022
    • Blueprint Medicines Corporation
    • Jason D. Brubaker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Inhibitors of RET

    • Patent number 11,279,688
    • Issue date Mar 22, 2022
    • Blueprint Medicines Corporation
    • Jason D. Brubaker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    PRKC fusions

    • Patent number 11,261,497
    • Issue date Mar 1, 2022
    • Blueprint Medicines Corporation
    • Nicolas Stransky
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Substituted pyrrolopyridines as inhibitors of activin receptor-like...

    • Patent number 11,236,086
    • Issue date Feb 1, 2022
    • Blueprint Medicines Corporation
    • Jason D. Brubaker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds and compositions useful for treating disorders related to...

    • Patent number 11,059,827
    • Issue date Jul 13, 2021
    • Blueprint Medicines Corporation
    • Steven Mark Wenglowsky
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Substituted pyrrolo[1,2-b]pyridazines for treating disorders relate...

    • Patent number 11,040,979
    • Issue date Jun 22, 2021
    • Blueprint Medicines Corporation
    • Brian L. Hodous
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    PIK3C2G fusions

    • Patent number 10,875,930
    • Issue date Dec 29, 2020
    • Blueprint Medicines Corporation
    • Nicolas Stransky
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

    • Patent number 10,774,070
    • Issue date Sep 15, 2020
    • Blueprint Medicines Corporation
    • Natasja Brooijmans
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Inhibitors of RET

    • Patent number 10,584,114
    • Issue date Mar 10, 2020
    • Blueprint Medicines Corporation
    • Jason D. Brubaker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    RAF1 fusions

    • Patent number 10,378,063
    • Issue date Aug 13, 2019
    • Blueprint Medicines Corporation
    • Nicolas Stransky
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    PRKC fusions

    • Patent number 10,370,724
    • Issue date Aug 6, 2019
    • Blueprint Medicines Corporation
    • Nicolas Stransky
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Compounds and compositions useful for treating disorders related to...

    • Patent number 10,370,379
    • Issue date Aug 6, 2019
    • BLUEPRINT MEDICINES CORPORATION
    • Steven Mark Wenglowsky
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion

    • Patent number 10,246,750
    • Issue date Apr 2, 2019
    • Blueprint Medicines Corporation
    • Nicolas Stransky
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Inhibitors of activin receptor-like kinase

    • Patent number 10,233,186
    • Issue date Mar 19, 2019
    • Blueprint Medicines Corporation
    • Natasja Brooijmans
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

    • Patent number 10,202,365
    • Issue date Feb 12, 2019
    • Blueprint Medicines Corporation
    • Natasja Brooijmans
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Inhibitors of RET

    • Patent number 10,183,928
    • Issue date Jan 22, 2019
    • Blueprint Medicines Corporation
    • Joseph L. Kim
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Inhibitors of RET

    • Patent number 10,030,005
    • Issue date Jul 24, 2018
    • Blueprint Medicines Corporation
    • Jason D. Brubaker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compositions useful for treating disorders related to kit

    • Patent number 9,994,575
    • Issue date Jun 12, 2018
    • Blueprint Medicines Corporation
    • Brian L. Hodous
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compositions useful for treating disorders related to kit

    • Patent number 9,994,552
    • Issue date Jun 12, 2018
    • Blueprint Medicines Corporation
    • Lucian V. DiPietro
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compositions useful for treating disorders related to kit

    • Patent number 9,944,651
    • Issue date Apr 17, 2018
    • Blueprint Medicines Corporation
    • Brian L. Hodous
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compositions useful for treating disorders related to kit

    • Patent number 9,884,861
    • Issue date Feb 6, 2018
    • Blueprint Medicines Corporation
    • Brian L. Hodous
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compositions useful for treating disorders related to kit

    • Patent number 9,499,522
    • Issue date Nov 22, 2016
    • Blueprint Medicines Corporation
    • Lucian V. DiPietro
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    INHIBITORS OF RET

    • Publication number 20240417386
    • Publication date Dec 19, 2024
    • Rigel Pharmaceuticals, Inc.
    • Jason D. Brubaker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

    • Publication number 20240382483
    • Publication date Nov 21, 2024
    • BLUEPRINT MEDICINES CORPORATION
    • Natasja Brooijmans
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CDK2 INHIBITORS

    • Publication number 20240383902
    • Publication date Nov 21, 2024
    • BLUEPRINT MEDICINES CORPORATION
    • Douglas Wilson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MAP4K1 INHIBITORS

    • Publication number 20240336630
    • Publication date Oct 10, 2024
    • BLUEPRINT MEDICINES CORPORATION
    • Jason D. Brubaker
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

    • Publication number 20240317757
    • Publication date Sep 26, 2024
    • BLUEPRINT MEDICINES CORPORATION
    • Brian L. Hodous
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

    • Publication number 20240308981
    • Publication date Sep 19, 2024
    • BLUEPRINT MEDICINES CORPORATION
    • Natasja Brooijmans
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

    • Publication number 20240299387
    • Publication date Sep 12, 2024
    • BLUEPRINT MEDICINES CORPORATION
    • Natasja Brooijmans
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    EGFR INHIBITORS

    • Publication number 20240300946
    • Publication date Sep 12, 2024
    • BLUEPRINT MEDICINES CORPORATION
    • Thomas A. Dineen
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    WILD TYPE KIT INHIBITORS

    • Publication number 20240262826
    • Publication date Aug 8, 2024
    • BLUEPRINT MEDICINES CORPORATION
    • Jason D. Brubaker
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

    • Publication number 20240158398
    • Publication date May 16, 2024
    • BLUEPRINT MEDICINES CORPORATION
    • Natasja Brooijmans
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    INHIBITORS OF PROTEIN KINASE A

    • Publication number 20240132490
    • Publication date Apr 25, 2024
    • BLUEPRINT MEDICINES CORPORATION
    • Neil Bifulco
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CDK2 INHIBITORS

    • Publication number 20230322791
    • Publication date Oct 12, 2023
    • BLUEPRINT MEDICINES CORPORATION
    • Douglas Wilson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CDK2 INHIBITORS

    • Publication number 20230159535
    • Publication date May 25, 2023
    • BLUEPRINT MEDICINES CORPORATION
    • Douglas Wilson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MAP4K1 INHIBITORS

    • Publication number 20230140954
    • Publication date May 11, 2023
    • BLUEPRINT MEDICINES CORPORATION
    • Jason D. Brubaker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

    • Publication number 20230129944
    • Publication date Apr 27, 2023
    • BLUEPRINT MEDICINES CORPORATION
    • Brian L. Hodous
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    EGFR INHIBITORS

    • Publication number 20230056541
    • Publication date Feb 23, 2023
    • BLUEPRINT MEDICINES CORPORATION
    • John Emmerson Campbell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    EGFR INHIBITORS

    • Publication number 20230026209
    • Publication date Jan 26, 2023
    • BLUEPRINT MEDICINES CORPORATION
    • Natasja Brooijmans
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MAP4K1 INHIBITORS

    • Publication number 20220323438
    • Publication date Oct 13, 2022
    • BLUEPRINT MEDICINES CORPORATION
    • Jason D. Brubaker
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

    • Publication number 20220315585
    • Publication date Oct 6, 2022
    • BLUEPRINT MEDICINES CORPORATION
    • Natasja Brooijmans
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    INHIBITORS OF RET

    • Publication number 20220315560
    • Publication date Oct 6, 2022
    • BLUEPRINT MEDICINES CORPORATION
    • Jason D. Brubaker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PRKC FUSIONS

    • Publication number 20220213553
    • Publication date Jul 7, 2022
    • BLUEPRINT MEDICINES CORPORATION
    • Nicolas Stransky
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    RAF1 FUSIONS

    • Publication number 20220205045
    • Publication date Jun 30, 2022
    • BLUEPRINT MEDICINES CORPORATION
    • Nicolas Stransky
    • G01 - MEASURING TESTING
  • Information Patent Application

    PYRROLOTRIAZINE DERIVATIVES FOR TREATING KIT-AND PDGFRA-MEDIATED DI...

    • Publication number 20220153748
    • Publication date May 19, 2022
    • BLUEPRINT MEDICINES CORPORATION
    • Joseph L. Kim
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

    • Publication number 20210284645
    • Publication date Sep 16, 2021
    • BLUEPRINT MEDICINES CORPORATION
    • Brian L. Hodous
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    INHIBITORS OF RET

    • Publication number 20200407341
    • Publication date Dec 31, 2020
    • BLUEPRINT MEDICINES CORPORATION
    • Jason D. Brubaker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED PYRROLOPYRIDINES AS INHIBITORS OF ACTIVIN RECEPTOR-LIKE...

    • Publication number 20200331908
    • Publication date Oct 22, 2020
    • BLUEPRINT MEDICINES CORPORATION
    • Jason D. Brubaker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR TREATING KIT- AND PDGFRA-MEDIATED DISE...

    • Publication number 20200325141
    • Publication date Oct 15, 2020
    • BLUEPRINT MEDICINES CORPORATION
    • Thomas A. Dineen
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    PRKC FUSIONS

    • Publication number 20200181715
    • Publication date Jun 11, 2020
    • BLUEPRINT MEDICINES CORPORATION
    • Nicolas Stransky
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    RAF1 FUSIONS

    • Publication number 20200172981
    • Publication date Jun 4, 2020
    • BLUEPRINT MEDICINES CORPORATION
    • Nicolas Stransky
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    PYRROLO[1,2-B]PYRIDAZINE COMPOUNDS AND COMPOSITIONS USEFUL FOR TREA...

    • Publication number 20200024280
    • Publication date Jan 23, 2020
    • BLUEPRINT MEDICINES CORPORATION
    • Brian L. Hodous
    • C07 - ORGANIC CHEMISTRY